You are here » Home » Companies » Company Overview » Earum Pharmaceuticals Ltd

Earum Pharmaceuticals Ltd.

BSE: 542724 Sector: Health care
NSE: N.A. ISIN Code: INE060601015
BSE 00:00 | 16 Sep 119.15 -2.85
(-2.34%)
OPEN

124.95

HIGH

125.00

LOW

116.50

NSE 05:30 | 01 Jan Earum Pharmaceuticals Ltd
OPEN 124.95
PREVIOUS CLOSE 122.00
VOLUME 59715
52-Week high 126.00
52-Week low 23.73
P/E 1702.14
Mkt Cap.(Rs cr) 147
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 124.95
CLOSE 122.00
VOLUME 59715
52-Week high 126.00
52-Week low 23.73
P/E 1702.14
Mkt Cap.(Rs cr) 147
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Earum Pharmaceuticals Ltd. (EARUMPHARMACEU) - Director Report

Company director report

(Pursuant to the provisions of Sub Section (3) of Section 134 of the Companies Act2013)

To

The Shareholders of

EARUM PHARMACEUTICALS LIMITED

On behalf of the Board of Directors it is our pleasure to present the 8 Annual Reporttogether with the Audited Statement of Accounts of EARUM PHARMACEUTICALS LIMITED(“the Company”) for the Financial Year ended 31%t March 2020.

FINANCIAL HIGHLIGHTS/PERFORMANCE OF THE COMPANY: The performance of the Company duringthe year has been as under:

31.03.2020 31.03.2019
Revenue From Operations 591088429 507000145
Other Income 22729804 533951
Total Revenue 973818233 507534096
Total Expenses 549367845 484766027
Profit/(Loss) Before Exceptional Items And Tax 244.51 227.68
Exceptional Items 0.00 0.00
Profit/(Loss) Before Tax 24450388 22768069
Tax Expenses
Current Tax 6298393 6154500
Deferred Tax 0 0
Income Tax Paid 0.00 0.00
Total Tax Expense 6298393 6154500
Profit/(Loss) For The Year 18151995 16613569

PERFORMANCE AND OPERATIONS

Your Company delivered yet another year of consistent and profitable growth. During theyear the company has earned total income of 573818233/- (Previous year 507534096/-).The Company continues to operate only in one segment ie pharmaceuticals intermediates andthere is no change in the nature of Business of the Company. After all the financialadjustments the company has earned a net profit after tax of 181 51995/-.

TRANSFER TO RESERVES

The company except its profits/losses does not propose any amount to transfer to theGeneral Reserves.

DIVIDEND:

Your Board of Directors is not recommended any dividend.

SUBSIDIARIES / ASSOCIATES:

Your Company had no subsidiaries Joint Venture or Associate Company during the yearunder review.

PARTICULARS OF LOANS GUARANTEES INVESTMENTS AND SECURITIES:

The details of Loans Guarantees Securities and Investments made during the financialyear ended 31st March 2020 are given in the notes to the Financial Statements incompliance with the provisions of Section 186 of the Companies Act 2013 read withCompanies (Meetings of Board and its Powers) Rules 2014.

CHANGES IN THE NATURE OF THE BUSINESS

There is no change in the nature of business of the Company.

DEPOSITS:

Your Company has not accepted any deposits during the year within the meaning ofSection 73 of the Companies Act 2013 and the Companies (Acceptance of Deposits) Rules2014.

PARTICULARS OF CONTRACTS OR ARRANGEMENTS WITH RELATED PARTIES REFFERED TO INSUB-SECTION (1) OF SECTION 188:

All transactions with related parties were in the ordinary course of business and atarm's length. The company has not entered into any transaction of a material nature withany of the related parties which are in conflict with the interest of the company. Thedetails of related party transactions are disclosed in AOC-2 attached to and forming partof the accounts.

EXTRACT OF ANNUAL RETURN:

Pursuant to Section 92(3) of the Companies Act 2013 (‘the Act') and rule 12(1) ofthe Companies (Management and Administration) Rules 2014 extract of annual return inForm MGT-9 is Annexed herewith as ‘Annexure-!'.

SHARE CAPITAL:

The Authorised Share Capital of the Company as on 31*t March 2020 was Rs. 70000000divided in 7000000 Equity Shares of Rs. 10/- each and the Paid-up Equity Share Capitalof the Company as on date was Rs. 61679100 divided in 6167910 Equity Shares of Rs.10/- each.

During the year under review the Company has issued 1848000 Equity shares withoutdifferential voting rights.

During the year under review the Company has 4011345 Bonus Share issued.

DIRECTORS AND KEY MANAGERIAL PERSONNEL:

The Board consists of Executive and Non-Executive Directors including IndependentDirectors who are having wide and varied experience in different disciplines of corporatefunctioning. The Directors and Key Managerial Personnel of the Company are:

S.NO NAME OF DIRECTOR'S /KMP POSITION HELD
1. Bhumishth Narendrabhai Patel Chairman & Managing Director
2. Payal Bhumishth Patel Wholetime Director & CFO
3 Narendrakumar Gangaramdas Director Patel
4. Hetarth Ashokkumar Patel Independent Director
D. Bhavik Shantilal Patel Independent Director
6. Ronak Narendra Lalwani Company Secretary

Mr. Parsotambhai Kantilal Purohit appointed as Whole time company secretary and KeyManagerial Personnel on 02"? April 2019 Pursuant to the provisions of CompaniesAct 2013.

Mrs. Payal Bhumishth Patel appointed as CFO and Key Managerial Personnel on 13th May2019 Pursuant to the provisions of Companies Act 2013.

During the financial year Mrs. Ashna Sangwan CFO and Key Managerial Personnel of thecompany resigned w.e.f. 13.05.2019 and relived from all his duties.

During the financial year Mr. Narendrakumar Gangaramdas Patel Director of the companyresigned w.e.f. 07.09.2019 and relived from all his duties.

Mr. Bhavik Shantilal Patel appointed as Additional Director on 12 September 2019Pursuant to the provisions of Companies Act 2013 and Regularization as Director of theCompany in Annual General Meeting on 27.09.2019.

During the financial year Mr. Alpesh Fatehsingh Purohit Director of the companyresigned w.e.f. 12.09.2019 and relived from all his duties.

Mr. Narendrakumar Gangaramdas Patel appointed as Additional Director on 26 December2019 Pursuant to the provisions of Companies Act 2013.

During the financial year Mr. Parsotambhai Kantilal Purohit Whole time companysecretary and Key Managerial Personnel of the company resigned w.e.f. 26.12.2019 andrelived from all his duties.

Mr. Ronak Narendra Lalwani appointed as Whole time company secretary and Key ManagerialPersonnel on 26th December 2019 Pursuant to the provisions of Companies Act 2013.

DIRECTORS RETIRE BY ROTATION:

As per the provisions of the Companies Act 2013 Mr. Narendrakumar Gangaramdas Patelretires by rotation at the forthcoming AGM and being eligible offers himself forreappointment. The Board recommends him reappointment.

PERFORMANCE EVALUATION OF THE BOARD:

During the year under review pursuant to the provisions of Section 178 of theCompanies Act 2013 and SEBI (Listing Obligations and Disclosure Requirements)Regulations 2015 the evaluation of performance of all Directors is undertaken annually.The company has implemented a system of evaluating performance of the Board of Directorsand of its Committees and individual Directors on the basis of a structured questionnairewhich comprise evaluation criteria taking into consideration various performance relatedaspects.

The Board of Directors has expressed their satisfaction with the valuation process.

DECLARATION GIVEN BY INDEPENDENT DIRECTORS:

The Company has received necessary declaration from all Independent Director as perSection 149(7) of the Companies Act 2013 that he/she meets the criteria of independencelaid down in Section 149(6) of the Companies Act 2013 and Regulation 16 (b) of SEBI(Listing Obligations and Disclosure Requirements) Regulation 2015.

NUMBER OF BOARD MEETINGS:

During the financial year under review 15 (Fifteen) Board Meetings were convened andheld. The intervening gap between the meetings was within the period of 120 days asprescribed under the Companies Act 2013 and Regulation 17 of SEBI Listing Regulations2015.

SN Date of Meeting Board Strength No. of Directors Present
01 02.04.2019 5 5
02 08.04.2019 5 5
03 09.04.2019 5 5
04 13.05.2019 5 5
05 13.06.2019 5 5
06 02.07.2019 5 5
07 02.08.2019 5 5
08 29.08.2019 5 5
09 07.09.2019 5 5
10 12.09.2019 4 4
11 14.09.2019 4 4
12 27.09.2019 4 4
13 14.10.2019 4 4
14 26.12.2019 4 4
15 21.03.2020 5 5

DIRECTORS' RESPONSIBILITY STATEMENT:

Pursuant to clause (c) of sub-Section (3) of Section 134 of the Act the Directorswould like to state that:

a) in the preparation of the annual accounts for financial year ended March 31 2020the applicable accounting standards have been followed along with proper explanationrelating to material departures;

b) the Directors have selected such accounting policies and applied them consistentlyand made judgments and estimates that are reasonable and prudent so as to give a true andfair view of the state of affairs of the Company as at March 31 2020 and of the profit ofthe Company for that period;

c) the Directors have taken proper and sufficient care for the maintenance of adequateaccounting records in accordance with the provisions of the Act for safeguarding theassets of the Company and for preventing and detecting fraud and other irregularities;

d) the Directors have prepared the annual accounts for the year ended March 31 2020on a going concern basis;

e) the Directors have laid down internal financial controls to be followed by theCompany and that such internal financial controls are adequate and are operatingeffectively; and

f) The Directors have devised proper systems to ensure compliance with the provisionsof all applicable laws and that such systems are adequate and operating effectively.

STATUTORY AUDITORS:

There are no qualifications reservations adverse remarks or disclaimers in theStatutory Auditor's Report on the Financial Statements of the Company for the financialyear 2019- 20 and hence does not require any explanations or comments.

STATUTORY AUDITOR REPORT:

A copy of the Auditor's Report for the year ended on March 31 2020 along with thestandalone financial statements thereon forms part of the Annual Report. The Notes onFinancial Statements referred to in the Auditor's Report are self-explanatory and do notcall for any further comments and there are no qualification remarks made by the Auditorsin their report hence no explanation is required in this regard.

The Statutory Auditors have not reported any incident of fraud to the Audit Committeeof the Company in the year under section 143(12) of the Companies Act 2013.

COST AUDITOR:

The Cost audit of the Company has not been conducted for the financial year 2019 -2020as provisions of Section 148 of the Companies Act 2013 are not applicable on the Company

SECRETARIAL AUDIT REPORT:

Pursuant to the provisions of section 204 of the Companies Act 2013 and the Companies(Appointment and Remuneration of Managerial Personnel) Rules 2014 the Company hasappointed M/s PRO & CO. Company Secretaries to undertake the Secretarial Audit of theCompany for the financial year 2019-20.

In terms of provisions of sub-section 1 of section 204 of the Companies Act 2013 theCompany has annexed to this Board Report as Annexure-II a Secretarial Audit Report givenby the Secretarial Auditor. The response of your directors on the observation made inSecretarial Audit Report is as follows:

Response to Point No. 1:

The Company is in process of finding suitable candidate to act as an Internal Auditor.

Response to Point No. 2:

The Company was submit Application for Correction in Master Data on 04.09.2020 withRegistrar Of Companies Gujarat Ahmedabad.

MANAGEMENT DISCUSSION AND ANALYSIS REPORT:

The Management Discussion and Analysis forms an integral part of this Report and givesdetails of the overall industry structure developments performance and state of affairsof the Company's business internal controls and their adequacy risk management systemsand other material developments during the financial year.

Management Discussion and Analysis Report is presented in a separate section forms partof the Annual Report as Annexure-II.

CODE OF CONDUCT FOR PREVENTION OF INSIDER TRADING

The Board of Directors has adopted the Insider Trading Policy in accordance with therequirements of the SEBI (Prohibition of Insider Trading) Regulation 2015. The InsiderTrading Policy of the Company lays down guidelines and procedures to be followed anddisclosures to be made while dealing with shares of the Company as well as theconsequences of violation. The policy has been formulated to regulate monitor and ensurereporting of deals by employees and to maintain the highest ethical standards of dealingin Company securities.

CORPORATE GOVERNANCE:

Your company believes that sound corporate Governance is critical for enhancing andretaining investor trust and your company always seeks to ensure that its performancegoals are met accordingly. The company has established systems and procedures to ensurethat its Board of Directors is well informed and well equipped to fulfill its overallresponsibilities and to provide management with the strategic direction needed to createlong term shareholders value. The company had adopted many ethical and transparentgovernance practices even before they were mandated by law. The company has always workedtowards building trust with shareholders employees customers suppliers and otherstakeholders based on the principles of good corporate goverence. However since thesecurities of the Company are listed on SME platform of BSE Limited pursuant to the SEBI(LODR) Regulations 2019 company is not required to attach report on Corporate Governanceto the report of Directors.

CORPORATE SOCIAL RESPONSIBILITY:

Pursuant to the provision of section 135 of the Companies Act 2013 the company is notrequired to undertake Corporate Social Responsibility activities.

SECRETARIAL STANDARDS OF ICSI

Pursuant to the approval given on 10‘ April 2015 by the Central Government to theSecretarial Standards specified by the Institute of Company Secretaries of India theSecretarial Standards on Meetings of the Board of Directors (SS-1) and General Meetings(SS-2) came into effect from 1 July 2015. The Company is in compliance with the same.

PARTICULARS OF EMPLOYEES:

There are no employees who are receiving remuneration exceeding of Rs. 8.5 lakh permonth or Rs. 1.20 Crore per annum under rule 5(2) of the Companies (Appointment andRemuneration of Managerial Personnel) Rules 2014.

ENERGY CONSERVATION TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND OUTGO: Theinformation pertaining to conservation of energy technology absorption Foreign exchangeEarnings and outgo as required under Section 134 (3)(m) of the Companies Act 2013 readwith Rule 8(3) of the Companies (Accounts) Rules 2014 is furnished as follows:

e CONSERVATION OF ENERGY

The steps taken or impact on conservation of energy; NIL

The steps taken by the company for utilizing alternate sources of energy; NIL

The capital investment on energy conservation equipments; NIL

e TECHNOLOGY ABSORPTION

the efforts made towards technology absorption: NIL

the benefits derived like product improvement cost reduction product developmentor import substitution: NIL

in case of imported technology (imported during the last three years reckoned from thebeginning of the financial year): NIL a. the details of technology imported: NA b. theyear of import: NA c. whether the technology been fully absorbed: NA d. if not fullyabsorbed areas where absorption has not taken place and the reasons thereof; and theexpenditure incurred on Research and Development: NA

e FOREIGN EXCHANGE EARNINGS AND OUTGO

During the period under review there was no foreign exchange earnings or out flow.

S. No. Particulars Current Year
(i) Foreign exchange earnings Nil
(ii) Foreign exchange outgo Nil

VIGIL MECHANISM

The Company has adopted a Whistle Blower Policy establishing vigil mechanism toprovide a formal mechanism to the Directors and employees to report concerns aboutunethical behavior actual or suspected fraud or violation of Code of Conduct and Ethics.It also provides for adequate safeguards against the victimization of employees who availof the mechanism and provides direct access to the Chairperson of the Audit Committee inexceptional cases. It is affirmed that no personnel of the Company has been denied accessto the Audit Committee. The Whistle Blower Policy aims for conducting the affairs in afair and transparent manner by adopting highest standards of professionalism honestyintegrity and ethical behavior.

RISK MANAGEMENT:

The Company has been undertaking periodic review of its operations to address variousrisks impacting it and consequently measures are taken to mitigate or minimize the risks.Normal foreseeable risks to the Company's assets are adequately covered by comprehensiveinsurance. The Company's risk management approach and practices continued to focus onminimizing the adverse impact of risks on its business objectives and to enable theCompany to leverage market opportunities based on risk-return parity.

COMMITTEES OF THE BOARD

The Board has 3 (Three) Committees - the Audit Committee Nomination and RemunerationCommittee and Stakeholders Relationship Committee. All committees consist of majority ofIndependent Directors.

MATERIAL CHANGES AND COMMITMENTS:

There were no material changes and commitments affecting the financial position of theCompany which has occurred from the end of financial year i.e. March 31 2020 to the dateof Directors Report.

DETAILS OF SIGNIFICANT & MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS ORTRIBUNALS IMPACATING THE GOING CONCERN STATUS AND COMPANY'S OPERATION IN FUTURE

During the year under review there was no such orders passed by the regulators orcourts or tribunals impacting the going concern status and company's operations in future.

INTERNAL CONTROL SYSTEMS AND THEIR ADEQUACY:

The Company has an Internal Control System commensurate with the size scale andcomplexity of its operations. To maintain its objectivity and independence the InternalAudit function reports to the Chairman of the Audit Committee of the Board.

The Internal Audit Department monitors and evaluates the efficacy and adequacy ofinternal control system in the Company its compliance with operating systems accountingprocedures and policies at all locations of the Company and its subsidiaries. Based on thereport of internal audit function process owners undertake corrective action in theirrespective areas and thereby strengthen the controls. Significant audit observations andcorrective actions thereon are presented to the Audit Committee of the Board.

GREEN INIATIVES

Electronic copies of the Annual Report 2019-2020 and Notice of the 8th Annual GeneralMeeting are sent to all members whose email addresses are registered with the Company/Depository Participant(s). For members who have not registered their email addressesphysical copies of the Annual Report 2019-2020 and the Notice of the 8t Annual GeneralMeeting under Section 101 of the Companies Act 2013 are send through permitted mode.Members requiring physical copies can send a request to the Company.

POLICY ON SEXUAL HARASSMENT

The company has in place a policy for prevention of sexual harassment in accordancewith the requirements of the Sexual Harassment of women at workplace (PreventionProhibition & Redressal) Act 2013. Internal Complaints Committee has been set up toredress complaints received regarding sexual harassment. All employees (permanentcontractual temporary trainees) are covered under this policy. The Company did notreceive any complain during the year 2019-20.

ACKNOWLEDGMENTS:

The Directors take this opportunity to place on record their sincere thanks to thesuppliers customers strategic partners Banks and Financial Institutions InsuranceCompanies Central and State Government Departments and the shareholders for their supportand co-operation extended to the Company from time to time. Directors are pleased torecord their appreciation of the sincere and dedicated services of the employees andworkmen at all levels

For and on behalf of Board
Bhumishth Patel Payal Bhumishth Patel
DIN: 02516641 DIN: 05300011
Managing Director Wholetime Director

Date: 04/12/2020 Place: Ahmedabad

FORM AOC -2

(Pursuant to clause (h) of sub-section (3) of section 134 of the Act and Rule 8(2) ofthe Companies (Accounts) Rules 2014)

Form for Disclosure of particulars of contracts/arrangements entered into by thecompany with related parties referred to in sub section (1) of section 188 of theCompanies Act 2013 including certain arms length transaction under third proviso thereto.

1.Details of contracts or arrangements or transactions not at Arm's length basis: NIL

S. No. Particulars Details
a) Name (s) of the related party & nature of relationship
b) Nature of contracts / arrangements / transaction
c) Duration of the contracts / arrangements / transaction
d) Salient terms of the contracts or arrangements or transaction including the value if any
e) Justification for entering into such contracts or arrangements or transactions'
f) Date of approval by the Board
g) Amount paid as advances if any
h) Date on which the special resolution was passed in General meeting as required under first proviso to section 188

2.Details of contracts or arrangements or transactions at Arm's length basis. NIL

S.No. Particulars Details
a) Name (s) of the related party & nature of relationship
b) Nature of contracts / arrangements / transaction
c) Duration of the contracts / arrangements / transaction
d) Salient terms of the contracts or arrangements or transaction including the value if any
e) Date of approval by the Board
f) Amount paid as advances if any
For EARUM PHARMACEUTICALS LIMITED
Bhumishth Patel
MANAGING DIRECTOR
DIN: 02516641

FORM NO. MGT 9 EXTRA CT OF ANNUAL RETURN

As on financial year ended on 31.03.2020

Pursuant to Section 92 (3) of the Companies Act 2013 and rule 12(1) of the Company(Management & Administration) Rules 2014.

I. REGISTRATION & OTHER DETAILS:
fe CIN U24230GJ2012PLC071299
Registration Date 26/Jul/12
Bla Name of the Company EARUM PHARMACEUTICALS LIMITED
Category/Sub-category of the Company Company Limited By Shares Indian Non Government Company
5 Address of the Registered office & contact details G1 Ground Floor V R Complex Near Sanathal Cross Road SP Ring Road Sanathal. Ahmedabad Gujarat - 382210
6_Whether listed company Yes (Listed)
7 Name Address & contact details of the Registrar & Transfer Agent if any. Bigshare Services Pvt. Ltd. Opp. Vasant OasisMakwana Road Marol Andheri East Mumbai 400059
Phone: 91-22-62638200

1st EmaillD: Floor bssahd@bigshareonline.com Bharat Tin Works Building

Il. PRINCIPAL BUSINESS ACTIVITIES OF THE COMPANY (All the business activitiescontributing 10 % or more of the total turnover of the company shall be stated)

S. No. Name and Description of main products / services NIC Code of the Product/service % to total turnover of the company
1 Pharma Intermediate 202 100%
Ill. SN PARTICULARS OF HOLDING SUBSIDIARY AND ASSOCIATE Name and address of the Company COMPANIES CIN/GLN Holding/ Subsidiary/ Associate % of shares Applicable Section
held

[IV.. SHARE HOLDING PATTERN (Equity share capital breakup as percentage of totalequity) (i) Category-wise Share Holding

Category of Shareholders No. of Shares held at the beginning of the year [As on 31-March-2019] No. of Shares held at the end of the year [As on 31-March-2020] % Change during the year
Demat Physical Total % of Total Shares Demat Physical Total % of Total Shares
A. Promoters
(1) Indian
a) Individual/ HUF 0 58372 308562 18.92 3502660 0 3502660 56.79 37.87
b) Central Govt 0 0 0 0.00 0 0 0 0.00 0.00
c) State Govt(s)} 0 0 0 0.00 0 0 0 0.00 0.00
d) Bodies Corp. 0 1 1 0.00 0 0 0 0.00 0.00
e) Banks / FI 0 0 0 0.00 0 0 0 0.00 0.00
f) Any other 0 250190 0 81.08 817222 0 817222 13.25 -67.83
Sub Total (A)(1} - 308563 308563 100.00 4319882 - 4319882 70.04 -29.96
(2) Foreign
a) NRI Individuals 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
b) Other Individuals 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
c) Bodies Corp. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
d) Any other 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Sub Total (A)}(2} 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
TOTAL (A) 0 308563 308563 100.00 4319882 0 4319882 70.04 -29.96
B. Public
1. Institutions
a) Mutual Funds 0 0 0 0.00 0 0 0 0.00 0.00
b) Banks / FI 0 0 0 0.00 0 0 0 0.00 0.00
c} Central Govt 0 0 0 0.00 0 0 0 0.00 0.00
d) State Govt(s) 0 0 0 0.00 0 0 0 0.00 0.00
e) Venture Capital 0 0 0 0.00 0 0 0 0.00 0.00
Funds
f} Insurance 0 0 0 0.00 0 0 0 0.00 0.00
g) Fils 0 0 0 0.00 0 0 0 0.00 0.00
h) Foreign Venture 0 0 0 0.00 0 0 0 0.00 0.00
Capital Funds
i) Others (specify) 0 0 0 0.00 0 0 0 0.00 0.00
Sub-total (B)(1): 0 0 0 0.00 0 0 0 0.00 0.00
2. Non-Institutions
a) Bodies Corp.
i} Indian 0 0 0 0.00 6000 0 6000 0.10 0.10
ii) Overseas 0 0 0 0.00 0 0 0 0.00 0.00
b) Individuals
i) Individual shareholders holding nominal share capital upto Rs. 1 lakh 0 2 2 0.00 75028 0 75028 1.22 1.22
ii) Individual shareholders holding nominal share capital in excess of Rs 1 lakh 0 0 0 0.00 1734000 0 1734000 28.11 28.11
c) Others (specify)
Non Resident 0 0 0 0.00 0 0 0 0.00 0.00
Indians/Overseas
Corporate Bodies
Foreign Nationals 0 0 0 0.00 0 0 0 0.00 0.00
Clearing Members 0 0 0 0.00 0 0 0 0.00 0.00
Trusts 0 0 0 0.00 0 0 0 0.00 0.00
Foreign Corporate 0 0 0 0.00 0 0 0 0.00 0.00
Body
HUF 0 0 0 0.00 33000 0 33000 0.53 0.53
Sub-total (B)(2): 0 2 2 0.00 1848028 0 1848028 29.96 29.96
Total Public (B) 0 2 2 0.00 1848028 0 1848028 29.96 29.96
C. Shares held by 0 0 0 0.00 0 0 0 0.00 0.00
Custodian for GDRs
& ADRs
Grand Total (A+B+C)} 0 308565 308565 100.00 6167910 0 6167910 100.00 0.00

(ii) Shareholding of Promoter

SN Shareholder's Name Shareholding

at the beginning of the year

Shareholding at the end of the year

% change in shareholdin 8 during the year
No. of Shares} %ofShares Shares ofthe company %oftotal Pledged/ encumbered to total shares No.ofShares}] %oftotal Shares of the company % of Shares Pledged/ encumbered to total shares
1 Bhumishth Narendrabhai Patel 125095 40.54 0.00 1751330 28.39 0.00 -12.15
2 Payal Bhumishth Patel 125095 40.54 0.00 1751330 28.39 0.00 -12.15
3 Narendrakumar Gangaramdas Patel 29185 9.46 0.00 408590 6.62 0.00 -2.84
4 Sushilabahen Narendrakumar Patel 29187 9.46 0.00 408618 6.62 0.00 -2.84
5 Auxilia Pharmaceuticals Private Limited 0 0.00 0.00 14 0.02 0.00 -0.02
Total 308562 100.00 0.00 4319882 70.04 0.00 -30.00

(iii) Change in Promoters' Shareholding (please specify if there is no change) NoChange During Year

SN Particulars Date Reason Shareholding at the

beginning of the year Cumulative Shareholding

during the year
No. of shares ' of total shares No. of shares ' of total shares
1 Bhumishth Narendrabhai Patel
At the beginning of the year 125095 2.03 125095 2.03
Date wise increase/decrease in Promoters Shareholding during the year specifying the reasons for increase/ decrease (e.g. allotment/ transfer/ bonus/ sweat equity etc.) 17.05.2019 Buy 1626235 28.39 1751330 28.39
01.07.2019 Sell 1751330 28.39 0 0.00
02.07.2019 Buy 1751330 28.39 1751330 28.39
At the end of the year 31.03.2020 1751330 28.39
2 Payal Bhumishth Patel
At the beginning of the year 125095 2.03 125095 2.03
Date wise increase/decrease in Promoters Shareholding during the year specifying the reasons for increase/ decrease (e.g. allotment/ transfer/ bonus/ sweat 4795 9019 Buy 1626235 28.39 1751330 28.39
01.07.2019 Sell 1751330 2839 0 0.00
02.07.2019 Buy 1751330 28.39 1751330 28.39
At the end of the year 31.03.2020 1751330 28.39
3 Narendrakumar Gangaramdas
Patel
At the beginning of the year 29185 0.47 29185 0.47
Date wise increase/decrease in Promoters Shareholding during the year specifying the reasons for increase/ decrease (e.g. allotment/ transfer/ bonus/ sweat 147.95 2019 Buy 379405 6.62 408590 6.62
01.07.2019 Sell 408590 6.62 0 0.00
02.07.2019 Buy 408590 6.62 408590 6.62
At the end of the year 31.03.2020 408590 6.62
4 Sushilabahen Narendrakumar
Patel
At the beginning of the year 29187 0.47 29187 0.47
Date wise increase/decrease in Promoters Shareholding during the year specifying the reasons for increase/ decrease (e.g. allotment/ transfer/ bonus/ sweat 147.95 2919 Buy 379431 6.62 408618 6.62
01.07.2019 {Sell 408618 6.62 0 0.00
02.07.2019 Buy 408618 6.62 408618 6.62
At the end of the year 31.03.2020 408618 6.62
5 Auxilia Pharmaceuticals
Private Limited
At the beginning of the year 0 0.00 0 0.00
Date wise increase/decrease in Promoters Shareholding during the year specifying the reasons for increase/ decrease (e.g. allotment/ transfer/ bonus/ sweat equity etc.) 12.04.2019 Buy 1 0.00 1 0.00
17.05.2019 Buy 13 0.00 14 0.00
01.07.2019 Sell 14 0.00 0 0.00
02.07.2019 Buy 14 0.00% 14 0.00
At the end of the year 31.03.2020 14 0.00

(iv) Shareholding Pattern of top ten Shareholders

(Other than Directors Promoters and Holders of GDRs and ADRs):

SN For each of the Top 10 shareholders during the year Date Reason Shareholding at the No. of shares beginning of the year % of total shares Cumulative No. of shares Shareholding % of total shares
1_ VISHAL MAHENDRABHAI THEKDI
At the beginning of the year 4/1/2019 - 0.00 - 0.00
Changes during the year 123000 1.99 123000 199
At the end of the year 3/31/2020 123000 1.99 123000 1.99
SHASHIKANT VEDPRAKASH SHARMA
At the beginning of the year 4/1/2019 : 0.00 - 0.00
Changes during the year 117014 1.90 117014 190
At the end of the year 3/31/2020 117014 1.90 117014 1.90
RIPALBEN V THEKADI
At the beginning of the year 4/1/2019 : 0.00 - 0.00
Changes during the year 117000 1.90 117000 190
At the end of the year 3/31/2020 117000 1.90 117000 1.90
4_PRITI CHANDRESH PATEL
At the beginning of the year 4/1/2019 : 0.00 - 0.00
Changes during the year 114000 1.85 114000 1.85
At the end of the year 3/31/2020 114000 1.85 114000 1.85
5 _ADITYA VIKRAMBHAI PATEL
At the beginning of the year 4/1/2019 - 0.00 - 0.00
Changes during the year 114000 1.85 114000 1.85
At the end of the year 3/31/2020 114000 1.85 114000 1.85
6_KAMALABEN GUNVANTLAL PATEL
At the beginning of the year 4/1/2019 : 0.00 - 0.00
Changes during the year 111000 1.80 111000 1.80
At the end of the year 3/31/2020 111000 1.80 111000 1.80
7_CHANDRESH D PATEL
At the beginning of the year 4/1/2019 : 0.00 - 0.00
Changes during the year 111000 1.80 111000 1.80
At the end of the year 3/31/2020 111000 1.80 111000 1.80
8 _VEDANT TARUNBHAI PATEL
At the beginning of the year 4/1/2019 - 0.00 - 0.00
Changes during the year 108000 1.75 108000 1.75
At the end of the year 3/31/2020 108000 1.75 108000 1.75
9 _RAKESHBHAI RASIKBHAI PATEL
At the beginning of the year 4/1/2019 : 0.00 - 0.00
Changes during the year 96000 1.56 96000 1.56
At the end of the year 3/31/2020 96000 1.56 96000 1.56
10 TARUNKUMAR GUNVANTLAL PATEL
At the beginning of the year 4/1/2019 : 0.00 - 0.00
Changes during the year 126000 2.04 126000 204
At the end of the year 3/31/2020 126000 2.04 126000 2.04

(v) Shareholding of Directors and Key Managerial Personnel:

SN Shareholding of each Directors and each Key Managerial Personnel Date Reason

Shareholding at the beginning of the year Cumulative Shareholding during the year

No. of shares % of total shares No. of shares % of total shares
1_Mr. BHUMISHTH NARENDRABHAI PATEL
At the beginning of the year 4/1/2019 125095 2.03 125095 2.03
Changes during the year 1626235 28.39 1751330 28.39
At the end of the year 3/31/2020 1751330 28.39 1751330 28.39
2_Mrs. PAYAL BHUMISHTH PATEL
At the beginning of the year 4/1/2019 125095 2.03 125095 2.03
Changes during the year 1626235 28.39 1751330 28.39
At the end of the year 3/31/2020 1751330 28.39 1751330 28.39
3 Mr. NARENDRAKUMAR GANGARAMDAS PATEL
At the beginning of the year 4/1/2019 29185.00 0.47 29185.00 0.47
Changes during the year 379405.00 6.62 408590.00 6.62
At the end of the year 3/31/2020 408590.00 6.62 408590.00 6.62
4 _Mr. HETARTH ASHOKKUMAR PATEL
At the beginning of the year 4/1/2019 0.00 0.00 0.00 0.00
Changes during the year 0.00 0.00 0.00 0.00
At the end of the year 3/31/2020 0.00 0.00 0.00 0.00
5_Mr. BHAVIK SHANTILAL PATEL
At the beginning of the year 4/1/2019 0.00 0.00 0.00 0.00
Changes during the year 0.00 0.00 0.00 0.00
At the end of the year 3/31/2020 0.00 0.00 0.00 0.00
6 Mr. RONAK NARENDRA LALWANI
At the beginning of the year 4/1/2019 0.00 0.00 0.00 0.00
Changes during the year 0.00 0.00 0.00 0.00
At the end of the year 3/31/2020 0.00 0.00 0.00 0.00

[v. INDEBTEDNESS

Indebtedness of the Company including interest outstanding/accrued but not due forpayment.

(Amt. Rs./Lacs)
Particulars Secured Loans excluding deposits Unsecured Loans Deposits Total Indebtedness
Indebtedness at the beginning of the financial year
i) Principal Amount 57994191.00 37825708.00 0.00 95819899.00
ii) Interest due but not paid 0.00 0.00 0.00 0.00
iii) Interest accrued but not due 5915920.00 3224428.00 0.00 9140348.00
Total (i+ii+iii) 63910111.00 41050136.00 0.00 104960247.00
Change in Indebtedness during the financial year
* Addition 16517571.00 -11319455.00 0.00 5198116.00
* Reduction 0.00 0.00 0.00 0.00
Net Change 16517571.00 -11319455.00 0.00 5198116.00
Indebtedness at the end of the financial year
i) Principal Amount 74492996.00 26782016.00 0.00 101275012.00
ii) Interest due but not paid 0.00 0.00 0.00 0.00
iii) Interest accrued but not due 5934686.00 2948665.00 0.00 8883351.00
Total (itii+iii) 80427682.00 29730681.00 0.00 110158363.00

[VI. REMUNERATION OF DIRECTORS AND KEY MANAGERIAL PERSONNEL

A. Remuneration to Managing Director Whole-time Directors and/or Manager:

SN. Particulars of Remuneration

Name of MD/WTD/ Manager

Total
Name BHUMISHTH NARENDRABHAI PATEL PAYAL BHUMISHTH PATEL (Rs/Lac}

DesignationManaging Director

Wholetime Director
1 Gross salary (a) Salary as per provisions contained in section 17(1) 1961 of the Income-tax Act
(b) Value of perquisites u/s 17(2) Income-tax Act 1961 - - -
(c) Profits in lieu of salary under section 17(3) Income- tax Act 1961
Option

-

-

~

2_Stock Equity

-

-

-

3_ [Sweat Commission

- -

- ~

- ~

4 - as % of profit

-

-

-

- others specify
please specify

-

-

-

5 Others

Total (A) as per the Act Ceiling

-

-

-

B. Remuneration to other Directors

SN. Particulars of Remuneration Name of Directors
NARENDRAKUMAR GANGARAMDAS PATEL HETARTH ASHOKKUMAR PATEL BHAVIK SHANTILAL PATEL
1 [Independent Directors
Fee for atten board committee me
Commission
Others please spe
Total (1
Other Non-Executive Directors
Fee for atten board committee me
Commission
Others please spe
Total (2
Total (B)=(1+2
Total Managerial Remuneration
Overall Ce as per the Act

C. Remuneration to K erial Personnel other than MD

SN. Particulars of Remuneration Name of K PAYAL BHUMISHTH RONAK NARENDRA PATEL erial Personnel LALWANI
De on CFO Co Se
Gross -
(a) Salary as per provisions contained in section 45000.00
17(1) of the Income-tax 1961
(b) Value of perquisites u/s 17(2) Income-tax
(c) Profits in lieu of salary under section 17(3) Income- tax 1961
Stock on Sweat E
Commission
- as % of profit
- others spe
Others please spe
Total 45000.00

 VII. PENALTIES / PUNISHMENT / COMPOUNDING OF OFFENCES:

Type Section of the Companies Act Brief Description Details of Penalty / Punishment/ Compounding fees imposed Authority [RD / NCLT/ COURT] Appeal made if any (give Details)
A. COMPANY
Penalty Nil Nil Nil Nil Nil
Punishment Nil Nil Nil Nil Nil
Compounding Nil Nil Nil Nil Nil
B. DIRECTORS
Penalty Nil Nil Nil Nil Nil
Punishment Nil Nil Nil Nil Nil
Compounding Nil Nil Nil Nil Nil
C. OTHER OFFICERS IN DEFAULT
Penalty Nil Nil Nil Nil Nil
Punishment Nil Nil Nil Nil Nil
Compounding Nil Nil Nil Nil Nil

.